glp-1 for bulimia While blockbuster drugs like Wegovy and Zepbound are known helping people lose weight, a new wave of people are using them to treat their eating disorders instead. Success, for them Beyond weight loss: Integrating GLP-1

These findings have provided valuable insights into the management of T2D and informed clinical practice guidelines and regulatory decisions.GLP-1 receptor agonists have emerged as an important therapeutic option for individuals with T2D, particularly those at high risk of CVD

In contrast, Goel et al., in a retrospective population-based cohort study of patients undergoing elective surgery, reported that active cannabis use disorder was associated with a significantly higher risk of postoperative myocardial infarction, with an adjusted odds ratio of 1.88 (95% CI, 1.312.69

Sometimes the simplest meals are the most sustainable

Most patients find these side effects are mild to moderate in severity and tend to diminish significantly after the first few weeks as the body adjusts to the medication

The cumulative incidence of NAION over 36 months was 6.7% for the semaglutide group versus 0.8% for the non-GLP-1 RA group